Monograph Title | Section | Source Publication | Page Number | Errata Post Date Sort ascending | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
INDOMETHACIN SODIUM | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 22-Nov-2024 | 1-Dec-2024 | NA | NA | In USP Reference Standards 〈11〉/USP Indomethacin Related Compound A RS: Change (C12H13NO3) to: C12H13NO3 AND In USP Reference Standards 〈11〉/USP Indomethacin Related Compound… Read More |
TAMSULOSIN HYDROCHLORIDE CAPSULES | ASSAY | USPNF Online | Online | 22-Nov-2024 | 1-Dec-2024 | NA | NA | In Procedure 1/Analysis: Change CS = concentration of USP Tamsulosin Hydrochloride RS in the Standard stock solution (mg/mL) to: CS = concentration of USP Tamsulosin Hydrochloride RS in the… Read More |
TAMSULOSIN HYDROCHLORIDE CAPSULES | PERFORMANCE TESTS | USPNF Online | Online | 22-Nov-2024 | 1-Dec-2024 | NA | NA | In Dissolution 〈711〉/Test 1/Analysis: Change Result3 = {[(C3 × V2) + (C2 + VS)] × (1/L) × 100} + Result1 to: Result3… Read More |
FLUCONAZOLE | IMPURITIES | USPNF Online | Online | 25-Oct-2024 | 1-Nov-2024 | NA | NA | In Organic Impurities/Analysis: Change Calculate the percentage of any individual unspecified impurity in the portion of Fluconazole taken: to: Calculate the percentage of any other specified and unspecified impurity in the portion of… Read More |
ALUMINUM SULFATE | CHEMICAL INFORMATION | USPNF Online | Online | 25-Oct-2024 | 1-Nov-2024 | NA | NA | Change Al2(SO4)3 · xH2O (anhydrous) 342.15 to: Al2(SO4)3 · xH2O AND Change Anhydrous 342.16 to: Anhydrous 342.13 |
RALBUMIN HUMAN | IMPURITIES | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Limit of High Molecular Weight Proteins: Change Acceptance criteria Individual impurities: NMT 1.0% to: Acceptance criteria: NMT 1.0% |
AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE CAPSULES | ASSAY | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Procedure/Buffer 1: Change tetrabutyl ammonium to: tetrabutylammonium |
FLUCONAZOLE TABLETS | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In USP Reference Standards <11>/USP Fluconazole Related Compound B RS: Change C13H13FN9O to: C13H13FN6O |
PHENOXYBENZAMINE HYDROCHLORIDE | ASSAY | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Procedure/Solution A: Change sodium phosphate monobasic to: sodium phosphate, monobasic, anhydrous |
CETIRIZINE HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Organic Impurities, Procedure 2/Solution A: Change tetrabutyl ammonium to: tetrabutylammonium |
MOXIFLOXACIN TABLETS | IMPURITIES | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Organic Impurities/Buffer: Change tetrabutyl ammonium to: tetrabutylammonium AND In Organic Impurities/Solution C: Change tetrabutyl ammonium to: tetrabutylammonium |
CALCITONIN SALMON | IMPURITIES | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Procedure: Related Peptides and Other Related Substances/Test 2: Change Resolution solution: to: System suitability solution: AND In Procedure: Related Peptides and Other Related Substances/Test 2… Read More |
KETOCONAZOLE | ASSAY | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Procedure/Buffer: Change tetrabutyl ammonium to: tetrabutylammonium |
RALBUMIN HUMAN | ASSAY | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Albumin Content/Native stock running buffer: Change glycerol to: glycine |
ADENOSINE | ASSAY | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Procedure/Buffer: Change tetrabutyl ammonium to: tetrabutylammonium |
CETIRIZINE HYDROCHLORIDE TABLETS | IMPURITIES | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Organic Impurities/Buffer: Change tetrabutyl ammonium to: tetrabutylammonium |
PACLITAXEL | IMPURITIES | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Organic Impurities/Table 4: Change a(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(Acetyloxy)-12-(benzyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-4,6,9,11-tetrahydroxy-4a,8,13,13-… Read More |
CALCITONIN SALMON | SPECIFIC TESTS | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Bioidentity/Medium B: Change 2 mM RPMI 1640 to: RPMI 1640 |
METHOTREXATE | ASSAY | USPNF Online | Online | 27-Sep-2024 | 1-Oct-2024 | NA | NA | In Procedure/Buffer: Correct the reagent cross reference 1 N sodium hydroxide to: 1 N sodium hydroxide |
POTASSIUM PHOSPHATES COMPOUNDED INJECTION | ASSAY | USPNF Online | Online | 30-Aug-2024 | 1-Sep-2024 | NA | NA | In Procedure for Potassium/Chromatographic system/Column: Change 4.6-mm × 25-cm; packing L97 to: 4-mm × 25-cm; packing L97 AND In Procedure for Phosphate/Chromatographic system/Column: Change 4.6-mm ×… Read More |
NICARDIPINE HYDROCHLORIDE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 26-Jul-2024 | 1-Aug-2024 | NA | NA | In USP Reference Standards <11>/USP Nicardipine Related Compound B RS: Change 3-{2-[Benzyl(methyl)amino]ethyl}5-methyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate oxalate. to: 3-{2-[Benzyl(methyl)amino]ethyl} 5-methyl 2,… Read More |
EXENATIDE INJECTION | PRODUCT-RELATED SUBSTANCES AND IMPURITIES | USPNF Online | Online | 26-Jul-2024 | 1-Aug-2024 | NA | NA | In Procedure/Chromatographic system/Column: Change 4.6-mm × 10-cm; 3-µm packing L52 to: 4.6-mm × 10-cm; 3-µm packing L52; two columns in series |
CRANBERRY FRUIT JUICE DRY EXTRACT | IDENTIFICATION | USPNF Online | Online | 26-Jul-2024 | 1-Aug-2024 | NA | NA | In A. HPTLC for Articles of Botanical Origin <203>/Sample solution: Change Mix 50 mg of Cranberry Fruit Juice Dry Extract with 7 mL of water. Sonicate for 10 min at room temperature, centrifuge, and save the supernatant. Precondition an… Read More |
NAPROXEN SODIUM | SPECIFIC TESTS | USPNF Online | Online | 28-Jun-2024 | 1-Aug-2024 | NA | NA | In Loss on Drying <731>/Analysis: Change Dry at 105° for 3 h. to: Dry in vacuum at 105° for 3 h. |
EDETATE DISODIUM COMPOUNDED OPHTHALMIC SOLUTION | DEFINITION | USPNF Online | Online | 28-Jun-2024 | 1-Jul-2024 | NA | NA | In two instances: Change to a pH between 6.5 and 7.5. to: to a pH between 6.1 and 7.1. |
DESCRIPTION AND SOLUBILITY | Hydrogenated Castor Oil | USPNF Online | Online | 28-Jun-2024 | 1-Aug-2026 | NA | NA | Change White, crystalline wax. Freely soluble in water, in saline TS, and in dextrose solutions; very slightly soluble in alcohol; practically insoluble in chloroform and in ether. Insoluble in water and in most common organic solvents. NF category:… Read More |
NEOMYCIN AND POLYMYXIN B SULFATES AND LIDOCAINE CREAM | ASSAY | USPNF Online | Online | 28-Jun-2024 | 1-Jul-2024 | NA | NA | Change Assay for neomycin—Proceed with Cream as directed in the Assay for neomycin under Neomycin and Polymyxin B Sulfates Cream. Assay for polymyxin B—Proceed with Cream as directed in the Assay for polymyxin B… Read More |
TYLOSIN INJECTION | SPECIFIC TESTS | USPNF Online | Online | 31-May-2024 | 1-Jun-2024 | NA | NA | Change pH 〈921〉 to: pH 〈791〉 |
CEFUROXIME AXETIL FOR ORAL SUSPENSION | ASSAY | USPNF Online | Online | 31-May-2024 | 1-Jun-2024 | NA | NA | In Procedure/System suitability: Change [Note—The relative retention times for acetanilide, cefuroxime axetil diastereoisomer B, cefuroxime axetil diastereoisomer A, and cefuroxime axetil delta-3 isomers are 0.4, 0.8, 0.9, and 1.0, respectively.]… Read More |
METRONIDAZOLE CAPSULES | IMPURITIES | USPNF Online | Online | 31-May-2024 | 1-Jun-2024 | NA | NA | In Organic Impurities: Change Mobile phase, Sample solution, and Chromatographic system: Proceed as directed in the Assay. to: Mobile phase and Chromatographic system: Proceed as directed in the … Read More |
PROCAINAMIDE HYDROCHLORIDE | ASSAY | USPNF Online | Online | 31-May-2024 | 1-Jun-2024 | NA | NA | In Resolution solution: Change p-aminoben zoic acid to: p-aminobenzoic acid |
DOCETAXEL | IMPURITIES | USPNF Online | Online | 31-May-2024 | 1-Jun-2024 | NA | NA | In Organic Impurities, Procedure 1: Change System suitability solution, Standard solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay. to: Mobile phase, Diluent, System… Read More |
RIVASTIGMINE TARTRATE | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In USP Reference Standards 〈11〉: Change USP Rivastigmine Tartrate R-Isomer RS to: USP Rivastigmine Tartrate R-Isomer RS (R)-3-[1-(Dimethylamino)ethyl]phenyl ethylmethylcarbamate, hydrogen tartrate. C14H22N2… Read More |
DOXORUBICIN HYDROCHLORIDE | ASSAY | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Procedure/System suitability solution: Add link to USP Store for USP Epirubicin Hydrochloride RS |
DILUTED ISOSORBIDE MONONITRATE | IMPURITIES | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Organic Impurities/Standard solution: Change isosorbide related compound A to: isosorbide mononitrate related compound A AND In System suitability/Suitability requirements/Relative standard… Read More |
BROMPHENIRAMINE MALEATE | SPECIFIC TESTS | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | Change Optical Rotation 〈781〉 to: Optical Rotation, Angular Rotation 〈781A〉 |
RIVASTIGMINE TARTRATE | IMPURITIES | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Organic Impurities/Procedure 1/Impurity Table 1/footnote d: Change 3-Nitrophenyl ethyl(methyl)carbamate. to: 4-Nitrophenyl ethyl(methyl)carbamate. |
ISOSORBIDE MONONITRATE TABLETS | IMPURITIES | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Organic Impurities/Standard solution: Change isosorbide related compound A to: isosorbide mononitrate related compound A AND In System suitability/Suitability requirements/Relative standard… Read More |
DAPSONE TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Dissolution 〈711〉/Standard solution: Change USP Dapsone RS of a known concentration in Medium to: (L/1000) mg/mL of USP Dapsone RS in Medium, where L is the label claim in mg/Tablet. Transfer a portion of this… Read More |
IPRATROPIUM BROMIDE INHALATION SOLUTION | IMPURITIES | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In Organic Impurities: Change Column: 4.6-mm × 25-µm; 5-µm packing L1 to: Column: 4.6-mm × 25-cm; 5-µm packing L1 |
ENSULIZOLE | IDENTIFICATION | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In B.: Change The retention time of the major peak of the Sample solution exhibits maxima and minima at the same wavelengths as those of the Standard solution, as obtained in the Assay. to: The retention time of the major… Read More |
SUCROSE | IMPURITIES | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In Sulfite/Analysis/footnote 1: Change Test kit for sulfite determination may be ordered from the following suppliers: Megazyme Ltd. (Product code: K-ETSULPH); R-Biopharm (Enzytec) (Article No.: E6275); BioSenTec/Nzytech (Catalogue No.: AK00071).… Read More |
LIDOCAINE | ASSAY | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In Procedure: Change Column: 3.9-mm × 30-cm; 4-µm packing L1 to: Column: 3.9-mm × 30-cm; 10-µm packing L1 |
LIDOCAINE, RACEPINEPHRINE AND TETRACAINE HYDROCHLORIDES COMPOUNDED TOPICAL GEL | DEFINITION | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | Change Prepare Lidocaine, Racepinephrine, and Tetracaine Hydrochlorides Compounded Topical Gel containing 40 mg/mL of lidocaine hydrochloride, 1 mg/mL of racepinephrine hydrochloride, and 10 mg/mL of tetracaine hydrochloride as follows (see Pharmaceutical… Read More |
IODIXANOL INJECTION | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | In USP Reference Standards 〈11〉/USP Iodixanol Related Compound E RS: Change 5-[[3-[[3-[[(2,3-Dihydroxypropyl)amino]carbonyl]-5- [[amino]carbonyl]-2,4,6-triiodophenyl](acetylimino)]-2-hydroxypropyl]-(acetylimino)]-N,N′-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-… Read More |
FLURAZEPAM HYDROCHLORIDE | USP REFERENCE STANDARDS 〈11〉 | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | In USP Flurazepam Related Compound C RS: Change 5-Chloro-2-(2-diethylaminoethyl(amino)-2′-fluorobenzophenone hydrochloride. to: 5-Chloro-2-(2-diethylaminoethylamino)-2′-fluorobenzophenone hydrochloride. |
PROPOFOL | ASSAY | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | In Procedure 2/Mobile phase: Change Hexane, acetonitrile, and alcohol (990: 7.5: 1) to: Hexane, acetonitrile, and alcohol, absolute (990: 7.5: 1) |
METHYLNALTREXONE BROMIDE | CHEMICAL INFORMATION | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | Correct the chemical structure |
IODIXANOL INJECTION | IMPURITIES | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | In Organic Impurities, Procedure 2/footnote 4: Change 5-[[3-[[3-[[[3-[[3-[[3,5-Bis-[[[2,3-dihydroxypropyl]amino]carbonyl]-2,4,6-triiodophenyl](acetylimino)]-2-hydroxypropyl](acetylimino)]-5-[[[2,3-dihydroxypropyl]amino]carbonyl]-2,4,6-triiodophenyl]carbonyl]amino]-2-hy… Read More |
THALIDOMIDE CAPSULES | ASSAY | USPNF Online | Online | 23-Feb-2024 | 1-Mar-2024 | NA | NA | In Procedure: Change 1000C(RU/RS) to: 500C(RU/RS) |